Assertio Holdings (ASRT) Asset Writedowns and Impairment (2023 - 2026)

Assertio Holdings' (ASRT) quarterly Asset Writedowns and Impairment came in at $198000.0 in Q1 2026, down 63.2% year-on-year from $538000.0 in Q1 2025, and up 107.4% quarter-over-quarter from -$2.7 million in Q4 2025.

Assertio Holdings (ASRT) Asset Writedowns and Impairment (2023 - 2026) Analysis & Trends

Assertio Holdings has disclosed Asset Writedowns and Impairment across 4 years of filings, most recently posting $198000.0 for Q1 2026.

  • Asset Writedowns and Impairment for Q1 2026 came in at $198000.0, down 63.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (down 83.39% YoY), and the FY2025 annual result was $1.7 million, down 67.41% from the prior year.
  • Asset Writedowns and Impairment came in at $198000.0 for Q1 2026 at Assertio Holdings, up from -$2.7 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $238.8 million in Q3 2023 to a low of -$2.7 million in Q4 2025.
  • The 4-year median for Asset Writedowns and Impairment is $1.9 million (2025), against an average of $25.5 million.
  • Across the five-year window, Asset Writedowns and Impairment gained 8.33% in 2024 and sank 151.44% in 2025, its largest moves.
  • Assertio Holdings' Asset Writedowns and Impairment stood at $4.8 million in 2023, then gained by 8.33% to $5.2 million in 2024, then slumped by 151.44% to -$2.7 million in 2025, then jumped by 107.4% to $198000.0 in 2026.
  • The last three Asset Writedowns and Impairment figures came in at $198000.0 (Q1 2026), -$2.7 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Assertio Holdings 150.94 Mn 79.37 Mn 7.22 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 198,000.00
Mar 31, 2026 198,000.00
Dec 31, 2025 -2.68 Mn
Dec 31, 2025 -2.68 Mn
Sep 30, 2025 1.70 Mn
Sep 30, 2025 1.70 Mn
Jun 30, 2025 2.14 Mn
Jun 30, 2025 2.14 Mn
Mar 31, 2025 538,000.00
Mar 31, 2025 538,000.00
Dec 31, 2024 5.20 Mn
Dec 31, 2024 5.20 Mn
Jun 30, 2024 2.45 Mn
Jun 30, 2024 2.45 Mn
Mar 31, 2024 1.43 Mn
Mar 31, 2024 1.43 Mn
Dec 31, 2023 4.80 Mn
Dec 31, 2023 4.80 Mn
Sep 30, 2023 238.80 Mn
Sep 30, 2023 238.80 Mn